NO20025882L - 5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)-tiazolidin- 2,4-dion hydriodid som farmasöytisk middel - Google Patents

5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)-tiazolidin- 2,4-dion hydriodid som farmasöytisk middel

Info

Publication number
NO20025882L
NO20025882L NO20025882A NO20025882A NO20025882L NO 20025882 L NO20025882 L NO 20025882L NO 20025882 A NO20025882 A NO 20025882A NO 20025882 A NO20025882 A NO 20025882A NO 20025882 L NO20025882 L NO 20025882L
Authority
NO
Norway
Prior art keywords
thiazolidine
pyridyl
ethoxy
benzyl
pharmaceutical
Prior art date
Application number
NO20025882A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025882D0 (no
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20025882D0 publication Critical patent/NO20025882D0/no
Publication of NO20025882L publication Critical patent/NO20025882L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20025882A 2000-06-08 2002-12-06 5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)-tiazolidin- 2,4-dion hydriodid som farmasöytisk middel NO20025882L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014005.3A GB0014005D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002545 WO2001094343A1 (en) 2000-06-08 2001-06-08 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical

Publications (2)

Publication Number Publication Date
NO20025882D0 NO20025882D0 (no) 2002-12-06
NO20025882L true NO20025882L (no) 2003-01-29

Family

ID=9893256

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025882A NO20025882L (no) 2000-06-08 2002-12-06 5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)-tiazolidin- 2,4-dion hydriodid som farmasöytisk middel

Country Status (26)

Country Link
US (1) US20040024027A1 (ko)
EP (1) EP1292595A1 (ko)
JP (1) JP2003535861A (ko)
KR (1) KR20030007919A (ko)
CN (1) CN1443185A (ko)
AP (1) AP2002002684A0 (ko)
AU (2) AU6255001A (ko)
BG (1) BG107356A (ko)
BR (1) BR0111508A (ko)
CA (1) CA2411064A1 (ko)
CZ (1) CZ20024029A3 (ko)
DZ (1) DZ3383A1 (ko)
EA (1) EA004298B1 (ko)
GB (1) GB0014005D0 (ko)
HU (1) HUP0301799A3 (ko)
IL (1) IL153280A0 (ko)
MA (1) MA26912A1 (ko)
MX (1) MXPA02012173A (ko)
NO (1) NO20025882L (ko)
NZ (1) NZ522997A (ko)
OA (1) OA12283A (ko)
PL (1) PL363683A1 (ko)
SK (1) SK17152002A3 (ko)
WO (1) WO2001094343A1 (ko)
YU (1) YU93002A (ko)
ZA (1) ZA200300017B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
JP2003535861A (ja) 2003-12-02
NZ522997A (en) 2004-05-28
YU93002A (sh) 2006-01-16
AP2002002684A0 (en) 2002-12-31
HUP0301799A2 (hu) 2003-12-29
GB0014005D0 (en) 2000-08-02
MA26912A1 (fr) 2004-12-20
ZA200300017B (en) 2004-04-08
KR20030007919A (ko) 2003-01-23
BR0111508A (pt) 2003-03-25
EA200300004A1 (ru) 2003-04-24
OA12283A (en) 2003-11-10
EA004298B1 (ru) 2004-02-26
CN1443185A (zh) 2003-09-17
US20040024027A1 (en) 2004-02-05
EP1292595A1 (en) 2003-03-19
BG107356A (bg) 2003-06-30
CZ20024029A3 (cs) 2003-04-16
IL153280A0 (en) 2003-07-06
CA2411064A1 (en) 2001-12-13
AU2001262550B2 (en) 2004-04-22
HUP0301799A3 (en) 2005-04-28
SK17152002A3 (sk) 2003-05-02
AU6255001A (en) 2001-12-17
WO2001094343A1 (en) 2001-12-13
PL363683A1 (en) 2004-11-29
NO20025882D0 (no) 2002-12-06
MXPA02012173A (es) 2003-04-25
DZ3383A1 (fr) 2001-12-13

Similar Documents

Publication Publication Date Title
DE60112729D1 (de) Hcl-salze von 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dion
DE60004196D1 (de) Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz
NO20003069D0 (no) 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin- 2,4-dion-maleinsyre-salt-hydrat som farmasøytikum
NO20031356L (no) Nye polymorfe former av 5-[4-[2-[N-metyl-N-(2- pyridyl]amino]etoksy]benzyl]tiazolidin-2,4-dionmaleat og fremgangsmåte for fremstilling avsamme
AU2002343036A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
NO20025882L (no) 5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)-tiazolidin- 2,4-dion hydriodid som farmasöytisk middel
AU8428401A (en) The hydrochloride salt of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione
IL188116A0 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
SI1265893T1 (sl) Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona
AU2002352479A1 (en) 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
AU2002352481A1 (en) 5- (4- (2- (n-methyl-n- (2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione nephtalenesulfonate salt and use against diabetes mellitus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application